Five years ago, the Melanoma Research Foundation (MRF) conducted an assessment of the challenges and opportunities facing the melanoma research community and patients with melanoma.
Archive | Scientific Publications
The State of Melanoma: Emergent Challenges and Opportunities
Posted in Melanoma News, Publications, Scientific Publications
Nivolumab plus ipilimumab for treatment-naïve metastatic uveal melanoma: An open-label, multicenter, phase II trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
In this single-arm, phase II trial, researchers sought to evaluate the effectiveness of the combination of nivolumab (nivo) plus ipilimumab (ipi) as a first-line therapy with respect to the 12-month overall survival (OS) in patients with metastatic uveal melanoma (MUM) who are not eligible for liver resection.
Posted in Melanoma News, Publications, Scientific Publications
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival
Thromboembolism (TE) in cancer significantly contributes to morbidity and mortality. Little is known about the incidence of arterial TE (ATE) and venous TE (VTE) in patients with melanoma on immune checkpoint inhibitor (ICI) therapy.
Posted in Melanoma News, Publications, Scientific Publications
The Yin and Yang of BRAF, MEK and CDK4-6 targeted therapy
A new paper from the McArthur & Sheppard Laboratory, by Emily Lelliott et. al.
Posted in Melanoma News, Health Professionals, Of Interest, Publications, Scientific Publications
